FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/11/029324 [Registered on: 24/11/2020] Trial Registered Prospectively
Last Modified On: 20/11/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Rheumatoid Arthritis and its management through Ayurveda  
Scientific Title of Study   A clinical study of the role of Ashwagandhadi Guggulu and Rasnadwadashak Kwath in the management of Aamvata W.S.R. to Rheumatoid Arthritis  
Trial Acronym  RA 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Vinod Gandharva  
Designation  MD Scholar 
Affiliation  DSRRAU, Jodhpur 
Address  P.G.Department of Kayachikitsa, University College of Ayurved, Dr Sarvepalli Radhakrishanan Rajasthan Ayurved University, Karwar, Nagaur Road, Jodhpur
P.G.Department of Kayachikitsa, University College of Ayurved, Dr Sarvepalli Radhakrishanan Rajasthan Ayurved University, Karwar, Nagaur Road, Jodhpur
Jodhpur
RAJASTHAN
342037
India 
Phone  9461199453  
Fax    
Email  vinod.gandharva86@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pramod Kumar Mishra 
Designation  Associate Professor & HOD 
Affiliation  DSRRAU, Jodhpur 
Address  P.G.Department of Kayachikitsa, University College of Ayurved, Dr Sarvepalli Radhakrishanan Rajasthan Ayurved University, Karwar, Nagaur Road, Jodhpur
P.G.Department of Kayachikitsa, University College of Ayurved, Dr Sarvepalli Radhakrishanan Rajasthan Ayurved University, Karwar, Nagaur Road, Jodhpur
Jodhpur
RAJASTHAN
342037
India 
Phone  9001009793  
Fax    
Email  drpramodmishra4@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Vinod Gandharva 
Designation  MD Scholar 
Affiliation  DSRRAU, Jodhpur 
Address  P.G.Department of Kayachikitsa, University College of Ayurved, Dr Sarvepalli Radhakrishanan Rajasthan Ayurved University, Karwar, Nagaur Road, Jodhpur
P.G.Department of Kayachikitsa, University College of Ayurved, Dr Sarvepalli Radhakrishanan Rajasthan Ayurved University, Karwar, Nagaur Road, Jodhpur
Jodhpur
RAJASTHAN
342037
India 
Phone  9461199453  
Fax    
Email  vinod.gandharva86@gmail.com  
 
Source of Monetary or Material Support  
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur 
 
Primary Sponsor  
Name  Dr Sarvepalli Radhakrisanan Rajasthan Ayurved University Jodhpur 
Address  P.G.Department of Kayachikitsa, University College of Ayurved, Dr Sarvepalli Radhakrishanan Rajasthan Ayurved University, Karwar, Nagaur Road, Jodhpur 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pramod Kumar Mishra  Dr. Sarvepaali Radhakrishanan Rajasthan Ayurved University, University Hospital of Ayurveda  OPD No.-3,P.G.Department of Kaya Chikitsa DSRRAU Karwar Nagaur road jodhpur
Jodhpur
RAJASTHAN 
9001009793

drpramodmishra4@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Ethics Committee DSRRAU Jodhpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M057||Rheumatoid arthritis with rheumatoid factor without organ or systems involvement. Ayurveda Condition: AMAVATAH,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ashwgandhadi Guggulu and Rasnadwadashak Kwath  Group-A Ashwgandhadi Guggulu, 3 Vati (Each of 250mg) twice a day orally with lukewarm water for 45 days. Group-B Rasnadwadashak Kwath, 40 ml twice a day orally for 45 days. Group-C Ashwgandhadi Guggulu, 3 Vati (Each of 250mg) twice a day orally with lukewarm water and Rasnadwadashak Kwath, 40 ml twice a day orally for 45 days. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. The Patients between the age group of 16 to 60 years in either sex presenting with clinical features of
Aamvata.
2. Pre-diagnosed and confirmed patients of Aamvata (Chronicity <6 years).
3. Patients willing to sign the consent form. 
 
ExclusionCriteria 
Details  1. Patients of age below 16 years and above 60 years of either sex.
2. Chronicity of Aamvata more than 6 years
3. Patients having Neoplasm of spine, Gout, Enclosing spondylitis, Traumatic arthritis and Pyogenic
Osteomyelitis, etc.
4. Patients having any severe disease like Cardiac disease, Pulmonary tuberculosis, Diabetes mellitus,
Renal function impairment, Hypertension etc.
5. Patients with extremely reduced joint space and having bone deformity.
6. Pregnant women and lactating mother. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in subjective and objective
parameters 
45 days 
 
Secondary Outcome  
Outcome  TimePoints 
To find out the comparative efficacy of the
treatment in the all groups
 
45 days 
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   30/11/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Aamvata ( Rheumatoid Arthritis) affects about 24.5% million people age of 2015. modern medical science achieved symptomatic relief but consequence is hazardous side effects to reverse or break the pathogenesis of the disease Aamvata. Therefor Ayurveda science may achieve a permanent treatment and root cause of this dangerous disease. The present study is a humble effort to treat the patients of Aamvata (Rheumatoid Arthritis) with Ashwagandhadi Guggulu and Rasnadwadashak Kawth.  
Close